Potentiation of nitric oxide-induced apoptosis in p53-/- vascular smooth muscle cells

Melina R Kibbe1, Jianrong Li, Suhua Nie

  • 1Department of Surgery, University of Pittsburgh, 677 Scaife Hall, Pittsburgh, PA 15261, USA. kibbemr@msx.upmc.edu

Insights

The tumor suppressor p53 normally protects vascular smooth muscle cells (VSMC) from nitric oxide (NO)-induced cell death. Loss of p53 increases VSMC sensitivity to NO-induced apoptosis, mediated by mitogen-activated protein kinase (MAPK) pathways.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cardiovascular Research

Background:

  • The role of the p53 tumor suppressor in nitric oxide (NO)-mediated apoptosis of vascular smooth muscle cells (VSMC) is not well understood.
  • Nitric oxide plays a critical role in vascular homeostasis and disease.

Purpose of the Study:

  • To investigate the functional role of p53 in NO-mediated VSMC apoptosis.
  • To elucidate the signaling pathways involved in this process.

Main Methods:

  • Vascular smooth muscle cells (VSMC) were isolated from p53 knockout (p53-/-) and wild-type (p53+/+) murine aortas.
  • Cells were exposed to exogenous or endogenous sources of NO.
  • Mitogen-activated protein kinase (MAPK) activation and apoptosis were assessed.
  • Specific MAPK inhibitors were used to block NO-induced apoptosis.

Main Results:

  • p53-/- VSMC exhibited significantly higher sensitivity to NO-induced apoptosis compared to p53+/+ VSMC.
  • This effect was specific to NO and not observed with other proapoptotic agents.
  • NO-induced apoptosis in p53-/- VSMC occurred independently of cyclic guanosine monophosphate (cGMP) generation.
  • NO treatment markedly activated p38 MAPK, c-Jun NH(2)-terminal kinase, MEK1/2, and ERK pathways in p53-/- VSMC.
  • Basal activity of the MEK-ERK pathway was elevated in p53+/+ VSMC.
  • Inhibition of p38 MAPK or MEK1/2 abolished NO-induced apoptosis.

Conclusions:

  • p53 acts as a protective factor against NO-mediated apoptosis in VSMC.
  • This protection is, in part, achieved through the differential regulation of MAPK signaling pathways.
  • These findings reveal a novel mechanism by which p53 influences vascular cell fate in response to NO.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...